Found: 13
Select item for more details and to access through your institution.
Chronic inflammation with microglia senescence at basal forebrain: impact on cholinergic deficit in Alzheimer's brain haemodynamics.
- Published in:
- Brain Communications, 2024, v. 6, n. 4, p. 1, doi. 10.1093/braincomms/fcae204
- By:
- Publication type:
- Article
The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 10, p. 1367, doi. 10.3390/cells12101367
- By:
- Publication type:
- Article
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury.
- Published in:
- Journal of Biomedical Science, 2023, v. 30, n. 1, p. 1, doi. 10.1186/s12929-023-00907-5
- By:
- Publication type:
- Article
Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 4, p. 1153, doi. 10.3390/ijms19041153
- By:
- Publication type:
- Article
Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson’s Disease.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 508, doi. 10.3390/ijms19020508
- By:
- Publication type:
- Article
(−)‐Phenserine tartrate (PhenT) as a treatment for traumatic brain injury.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 6, p. 636, doi. 10.1111/cns.13274
- By:
- Publication type:
- Article
Microglial Nogo delays recovery following traumatic brain injury in mice.
- Published in:
- Glia, 2023, v. 71, n. 10, p. 2473, doi. 10.1002/glia.24436
- By:
- Publication type:
- Article
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 5, p. 747, doi. 10.3390/biom13050747
- By:
- Publication type:
- Article
Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102449
- By:
- Publication type:
- Article
3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 950, doi. 10.3390/pharmaceutics14050950
- By:
- Publication type:
- Article
Mitigating chronic neuroinflammation in Alzheimer mice by novel immunomodulatory imide drugs (IMiDs) conserves neuroplasticity and cognitive function and also alleviates neurodegeneration‐behavioral impairments in TBI‐challenged mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080689
- By:
- Publication type:
- Article
Targeting neuroinflammation reduces synaptic, neuronal and cognitive loss in 5xFAD Alzheimer mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.061558
- By:
- Publication type:
- Article
Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 2327, doi. 10.1002/alz.12610
- By:
- Publication type:
- Article